HPL Electric & Power Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:21 am

Competitors of HPL Electric & Power Ltd

All Competitor Stocks of HPL Electric & Power Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:30 am

Below is a detailed analysis of the quarterly data for HPL Electric & Power Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 383.00 Cr.. The value appears to be declining and may need further review. It has decreased from 493.00 Cr. (Mar 2025) to 383.00 Cr., marking a decrease of 110.00 Cr..
• For Expenses, as of Jun 2025, the value is 325.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 410.00 Cr. (Mar 2025) to 325.00 Cr., marking a decrease of 85.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 24.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to 15.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 19.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.87. The value appears to be declining and may need further review. It has decreased from 5.78 (Mar 2025) to 2.87, marking a decrease of 2.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:11 am

Growth

Last Updated: September 5, 2025, 6:30 am

Balance Sheet

Last Updated: June 16, 2025, 12:00 pm

Below is a detailed analysis of the balance sheet data for HPL Electric & Power Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 64.00 Cr..
• For Reserves, as of Mar 2025, the value is 851.00 Cr.. The value appears strong and on an upward trend. It has increased from 764.00 Cr. (Mar 2024) to 851.00 Cr., marking an increase of 87.00 Cr..
• For Borrowings, as of Mar 2025, the value is 639.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 627.00 Cr. (Mar 2024) to 639.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 540.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 419.00 Cr. (Mar 2024) to 540.00 Cr., marking an increase of 121.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,095.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,874.00 Cr. (Mar 2024) to 2,095.00 Cr., marking an increase of 221.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 498.00 Cr.. The value appears strong and on an upward trend. It has increased from 461.00 Cr. (Mar 2024) to 498.00 Cr., marking an increase of 37.00 Cr..
• For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,589.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,403.00 Cr. (Mar 2024) to 1,589.00 Cr., marking an increase of 186.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,095.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,874.00 Cr. (Mar 2024) to 2,095.00 Cr., marking an increase of 221.00 Cr..

Notably, the Reserves (851.00 Cr.) exceed the Borrowings (639.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for HPL Electric & Power Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 6.78 (Mar 24) to 14.58, marking an increase of 7.80.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 6.78 (Mar 24) to 14.58, marking an increase of 7.80.
• For Cash EPS (Rs.), as of Mar 25, the value is 21.17. This value is within the healthy range. It has increased from 12.80 (Mar 24) to 21.17, marking an increase of 8.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 142.32. It has increased from 129.10 (Mar 24) to 142.32, marking an increase of 13.22.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 142.32. It has increased from 129.10 (Mar 24) to 142.32, marking an increase of 13.22.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 264.42. It has increased from 227.19 (Mar 24) to 264.42, marking an increase of 37.23.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 40.36. This value is within the healthy range. It has increased from 30.54 (Mar 24) to 40.36, marking an increase of 9.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 33.80. This value is within the healthy range. It has increased from 24.53 (Mar 24) to 33.80, marking an increase of 9.27.
• For PBT / Share (Rs.), as of Mar 25, the value is 19.85. This value is within the healthy range. It has increased from 10.59 (Mar 24) to 19.85, marking an increase of 9.26.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 14.62. This value is within the healthy range. It has increased from 6.78 (Mar 24) to 14.62, marking an increase of 7.84.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 6.78 (Mar 24) to 14.58, marking an increase of 7.80.
• For PBDIT Margin (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has increased from 13.44 (Mar 24) to 15.26, marking an increase of 1.82.
• For PBIT Margin (%), as of Mar 25, the value is 12.78. This value is within the healthy range. It has increased from 10.79 (Mar 24) to 12.78, marking an increase of 1.99.
• For PBT Margin (%), as of Mar 25, the value is 7.50. This value is below the healthy minimum of 10. It has increased from 4.66 (Mar 24) to 7.50, marking an increase of 2.84.
• For Net Profit Margin (%), as of Mar 25, the value is 5.52. This value is within the healthy range. It has increased from 2.98 (Mar 24) to 5.52, marking an increase of 2.54.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.51. This value is below the healthy minimum of 8. It has increased from 2.98 (Mar 24) to 5.51, marking an increase of 2.53.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.24. This value is below the healthy minimum of 15. It has increased from 5.25 (Mar 24) to 10.24, marking an increase of 4.99.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.47. This value is within the healthy range. It has increased from 16.43 (Mar 24) to 22.47, marking an increase of 6.04.
• For Return On Assets (%), as of Mar 25, the value is 4.47. This value is below the healthy minimum of 5. It has increased from 2.32 (Mar 24) to 4.47, marking an increase of 2.15.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.02, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.69. This value is within the healthy range. It has decreased from 0.72 (Mar 24) to 0.69, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has increased from 0.81 (Mar 24) to 0.85, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.51 (Mar 24) to 1.39, marking a decrease of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.77, marking a decrease of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 4. It has increased from 1.88 (Mar 24) to 1.93, marking an increase of 0.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.75 (Mar 24) to 0.00, marking a decrease of 14.75.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.82 (Mar 24) to 0.00, marking a decrease of 7.82.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.25 (Mar 24) to 0.00, marking a decrease of 85.25.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.18 (Mar 24) to 0.00, marking a decrease of 92.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 3. It has increased from 2.19 (Mar 24) to 2.89, marking an increase of 0.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 3. It has increased from 1.49 (Mar 24) to 2.05, marking an increase of 0.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,230.48. It has increased from 2,599.47 (Mar 24) to 3,230.48, marking an increase of 631.01.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
• For EV / EBITDA (X), as of Mar 25, the value is 12.45. This value is within the healthy range. It has decreased from 13.24 (Mar 24) to 12.45, marking a decrease of 0.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.56, marking an increase of 0.17.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 85.24 (Mar 24) to 0.00, marking a decrease of 85.24.
• For Price / BV (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has increased from 2.46 (Mar 24) to 2.90, marking an increase of 0.44.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.56, marking an increase of 0.17.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness